Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVH.L Regulatory News (CVH)

  • There is currently no data for CVH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Cavanagh Group plc

5 Apr 2011 09:37

RNS Number : 3148E
Cavanagh Group PLC
05 April 2011
 



FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the person whose positions/dealings are being disclosed:

David Taylor

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Cavanagh Group plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

04/04/2011

(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?

/NO

If YES, specify which:

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

108,617

0.94

(2) Derivatives (other than options):

(3) Options and agreements to purchase/sell:

 

TOTAL:

108,617

0.94

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

 

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

04/04/2011

Contact name:

David Taylor

Telephone number:

01444 475457 Office or 07802 302682 Mobile

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETZMGGDRKVGMZG
Date   Source Headline
13th Nov 20237:00 amRNS3rd Quarter and 9 Month Results
6th Nov 20233:10 pmRNSExpected Delisting of Global Depositary Shares
11th Aug 20237:28 amRNSFirst Half and Second Quarter 2023 Results
11th May 20238:16 amRNS1st Quarter Results
4th May 202310:16 amRNSPayment of Dividends in kind
4th May 202310:15 amRNSAudit Committee
2nd May 20237:00 amRNSDirectorate Information
2nd May 20237:00 amRNSAGM Statement
2nd May 20237:00 amRNSAnnual Financial Report
20th Apr 20238:01 amRNSCNV Approves Subsidiary Merger Prospectus
14th Apr 20237:00 amRNSResponse to Shareholder Information Request
23rd Mar 20233:00 pmRNSCVH Calls Annual Shareholders’ Meeting
14th Mar 202311:11 amRNSLeave of Absence
13th Mar 20234:56 pmRNSFull Year and Last Quarter 2022 Results
13th Mar 20237:00 amRNSBoard of Directors Approves Subsidiary Merger
6th Mar 20237:00 amRNSWebcast to discuss 4Q and FY 2022 results
20th Feb 20237:00 amRNSComposition of Audit Committee
16th Jan 20236:15 pmRNSSecretary of Trade imposes Fine on Subsidiary
7th Dec 20227:00 amRNSDirectorate Change
7th Dec 20227:00 amRNSClass “A” Shareholders’ Meeting
23rd Nov 20226:21 pmRNSNotice of Class "A" Shareholders' Meeting
23rd Nov 20226:19 pmRNSPresident of the Board Tenders Resignation
18th Nov 20227:28 amRNSPresident of the Board Tenders Resignation
11th Nov 20227:57 amRNSNine months and Third Quarter 2022 Results
31st Oct 20228:07 amRNSNotice of Results
11th Aug 20227:32 amRNSFirst Half and Second Quarter 2022 Results
25th Jul 20226:21 pmRNSNotice of Results
12th Jul 20227:48 amRNSPayment of Dividends in Kind
11th Jul 20229:02 amRNSAnnual Shareholders’ Meeting
11th Jul 20228:58 amRNSPayment of Dividends in Kind
5th Jul 20223:03 pmRNSAmended and Restated Deposit Agreement
5th Jul 20221:03 pmRNSResponse to Shareholder information Request
23rd Jun 20227:29 amRNSResponse to Shareholder Information Request
6th Jun 20227:00 amRNSBoard Calls Extraordinary Shareholders' Meeting
12th May 20227:00 amRNS1st Quarter 2022 Results
4th May 20227:50 amRNSMembership of Audit Committee
3rd May 20227:00 amRNSWebcast presentation to discuss 1Q 2022 results
29th Apr 20228:23 amRNSList of the Company Authorities
29th Apr 20228:19 amRNSAGM Statement
14th Apr 20227:00 amRNSResponse to Shareholder Information Request
14th Apr 20227:00 amRNSResignation of Member of Supervisory Committee
18th Mar 20221:05 pmRNSCVH Calls Annual Shareholders' Meeting
16th Mar 20227:04 amRNSAppointment of alternate market relations officer
11th Mar 20228:56 amRNSFull Year and Last Quarter 2021 Results
18th Feb 20228:40 amRNSSupreme Court dismisses Government Appeal
10th Nov 20217:50 amRNSNine months and Third Quarter 2021 Results
2nd Sep 202111:44 amRNSCVH Announces Payment of Dividends in Kind
2nd Sep 202111:24 amRNSCVH announces payments of dividends in kind
2nd Sep 202111:22 amRNSCVH Holds Extraordinary Shareholders Meeting
23rd Aug 20217:00 amRNSDirector/PDMR Shareholding - Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.